Fluconazole plus allopurinol in treatment of visceral leishmaniasis

J Antimicrob Chemother. 1996 May;37(5):1042-3. doi: 10.1093/jac/37.5.1042.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acquired Immunodeficiency Syndrome / complications
  • Acquired Immunodeficiency Syndrome / drug therapy
  • Adult
  • Allopurinol / therapeutic use*
  • Antifungal Agents / therapeutic use
  • Antimetabolites / therapeutic use
  • Bone Marrow / microbiology
  • Drug Therapy, Combination
  • Enzyme Inhibitors / therapeutic use
  • Female
  • Fluconazole / therapeutic use*
  • Humans
  • Immunocompromised Host
  • Kidney Transplantation
  • Leishmaniasis, Visceral / complications
  • Leishmaniasis, Visceral / drug therapy*
  • Male

Substances

  • Antifungal Agents
  • Antimetabolites
  • Enzyme Inhibitors
  • Allopurinol
  • Fluconazole